Establishing a culture of blood management through education: A quality initiative study of postoperative blood use in CABG patients at methodist debakey heart & Vascular Center

American Journal of Medical Quality

Volumn 26, Issue 5, 2011, Pages 349-356

  Masud, Faisal ^a,b   Larson Pollock, Karin ^a   Leveque, Christopher ^a   Vykoukal, Daynene ^a,c  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

blood management; CABG; postoperative blood use; transfusion

Indexed keywords

ARTICLE; BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION; CORONARY ARTERY BYPASS GRAFT; HEALTH CARE QUALITY; HUMAN; IN SERVICE TRAINING; INTENSIVE CARE UNIT; METHODOLOGY; ORGANIZATION; ORGANIZATION AND MANAGEMENT; PATIENT CARE; POSTOPERATIVE CARE; STATISTICS;

BLOOD COMPONENT TRANSFUSION; BLOOD TRANSFUSION; CORONARY ARTERY BYPASS; HUMANS; INSERVICE TRAINING; INTENSIVE CARE UNITS; ORGANIZATIONAL CULTURE; PATIENT CARE TEAM; POSTOPERATIVE CARE; QUALITY OF HEALTH CARE;

EID: 80051946810     PISSN: 10628606     EISSN: 1555824X     Source Type: Journal    
DOI: 10.1177/1062860611398532     Document Type: Article

References (51)

1. Cremieux PY,Barrett B,Anderson K,Slavin MB.Cost of outpatient blood transfusion in cancer patients.J Clin Oncol. 2000;18:2755-2761.
2. Goodman C,Chan S,Collins P,Haught R,Chen YJ.Ensuring blood safety and availability in the US: technological advances, costs, and challenges to payment: final report.Transfusion. 2003;43 (8): 3S-46S.
3. Jaspan D.Erythropoietic therapy: cost efficiency and reimbursement.Am J Health Syst Pharm. 2007;64 (16): S19-S29.
4. Shander A,Hofmann A,Gombotz H,Theusinger OM,Spahn DR.Estimating the cost of blood: past, present, and future directions.Best Pract Res Clin Anaesthesiol. 2007;21:271-289.
5. AABB. The 2007 national blood collection and utilization survey report. http://www.aabb.org/programs/biovigilance/nbcus/Documents/07nbcusrpt.pdf. Accessed April 15, 2011.
6. Corwin HL,Gettinger A,Pearl RG, et al.The CRIT Study: anemia and blood transfusion in the critically ill-current clinical practice in the United States.Crit Care Med. 2004;32:39-52.
7. Hébert PC,Wells G,Blajchman MA, et al.A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.N Engl J Med. 1999;340:409-417.
8. Madjdpour C,Spahn DR.Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications.Br J Anaesth. 2005;95:33-42.
9. Palmieri TL,Caruso DM,Foster KN, et al.Effect of blood transfusion on outcome after major burn injury: a multicenter study.Crit Care Med. 2006;34:1602-1607.
10. Rao MP,Boralessa H,Morgan C, et al.Blood component use in critically ill patients.Anaesthesia. 2002;57:530-534.
11. Shapiro MJ,Gettinger A,Corwin HL, et al.Anemia and blood transfusion in trauma patients admitted to the intensive care unit.J Trauma. 2003;55:269-273.
12. Vamvakas EC,Blajchman MA.Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention.Blood. 2009;113:3406-3417.
13. Vincent JL,Baron JF,Reinhart K, et al.Anemia and blood transfusion in critically ill patients.JAMA. 2002;288:1499-1507.
14. Taylor RW,O'Brien J,Trottier SJ, et al.Red blood cell transfusions and nosocomial infections in critically ill patients.Crit Care Med. 2006;34:2302-2308.
15. Hendrickson JE,Hillyer CD.Noninfectious serious hazards of transfusion.Anesth Analg. 2009;108:759-769.
16. Chaiwat O,Lang JD,Vavilala MS, et al.Early packed red blood cell transfusion and acute respiratory distress syndrome after trauma.Anesthesiology. 2009;110:351-360.
17. Holness L,Knippen MA,Simmons L,Lachenbruch PA.Fatalities caused by TRALI.Transfus Med Rev. 2004;18:184-188.
18. Marik PE,Corwin HL.Acute lung injury following blood transfusion: expanding the definition.Crit Care Med. 2008;36:3080-3084.
19. Popovsky MA,Abel MD,Moore SB.Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies.Am Rev Respir Dis. 1983;128:185-189.
20. Triulzi DJ.Transfusion-related acute lung injury: current concepts for the clinician.Anesth Analg. 2009;108:770-776.
21. Triulzi DJ,Kleinman S,Kakaiya RM, et al.The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy.Transfusion. 2009;49:1825-1835.
22. FDA Patient Safety News. Avoiding deaths from blood transfusions. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/transcript.cfm?show=32#4. Accessed October 5, 2010.
23. Garratty G.The James Blundell Award Lecture 2007: do we really understand immune red cell destruction?.Transfus Med. 2008;18:321-334.
24. Linden JV,Wagner K,Voytovich AE,Sheehan J.Transfusion errors in New York State: an analysis of 10 years' experience.Transfusion. 2000;40:1207-1213.
25. Blumberg N.Deleterious clinical effects of transfusion immunomodulation: proven beyond a reasonable doubt.Transfusion. 2005;45 (2): 33S-39S.
26. Ruhl H,Bein G,Sachs UJ.Transfusion-associated graft-versus-host disease.Transfus Med Rev. 2009;23:62-71.
27. Shivdasani RA,Haluska FG,Dock NL,Dover JS,Kineke EJ,Anderson KC.Brief report: graft-versus-host disease associated with transfusion of blood from unrelated HLA-homozygous donors.N Engl J Med. 1993;328:766-770.
28. Domen RE,Hoeltge GA.Allergic transfusion reactions: an evaluation of 273 consecutive reactions.Arch Pathol Lab Med. 2003;127:316-320.
29. Skeate RC,Eastlund T.Distinguishing between transfusion related acute lung injury and transfusion associated circulatory overload.Curr Opin Hematol. 2007;14:682-687.
30. Tobian AA,Sokoll LJ,Tisch DJ,Ness PM,Shan H.N-terminal pro-brain natriuretic peptide is a useful diagnostic marker for transfusion-associated circulatory overload.Transfusion. 2008;48:1143-1150.
31. Murray DJ,Pennell BJ,Weinstein SL,Olson JD.Packed red cells in acute blood loss: dilutional coagulopathy as a cause of surgical bleeding.Anesth Analg. 1995;80:336-342.
32. Dzik WH,Kirkley SA.Citrate toxicity during massive blood transfusion.Transfus Med Rev. 1988;2:76-94.
33. Bennett-Guerrero E,Veldman TH,Doctor A, et al.Evolution of adverse changes in stored RBCs.Proc Natl Acad Sci U S A. 2007;104:17063-17068.
34. Koch CG,Li L,Sessler DI, et al.Duration of red-cell storage and complications after cardiac surgery.N Engl J Med. 2008;358:1229-1239.
35. Ferraris VA,Ferraris SP.Limiting excessive postoperative blood transfusion after cardiac procedures: a review.Tex Heart Inst J. 1995;22:216-230.
36. Ferraris VA,Ferraris SP,Saha SP, et al.Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline.Ann Thorac Surg. 2007;83 (5): S27-S86.
37. Murphy GJ,Reeves BC,Rogers CA,Rizvi SI,Culliford L,Angelini GD.Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery.Circulation. 2007;116:2544-2552.
38. Koch CG,Li L,Duncan AI, et al.Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting.Crit Care Med. 2006;34:1608-1616.
39. Surgenor SD,Kramer RS,Olmstead EM, et al.The association of perioperative red blood cell transfusions and decreased long-term survival after cardiac surgery.Anesth Analg. 2009;108:1741-1746.
40. Engoren MC,Habib RH,Zacharias A,Schwann TA,Riordan CJ,Durham SJ.Effect of blood transfusion on long-term survival after cardiac operation.Ann Thorac Surg. 2002;74:1180-1186.
41. Koch CG,Li L,Duncan AI, et al.Transfusion in coronary artery bypass grafting is associated with reduced long-term survival.Ann Thorac Surg. 2006;81:1650-1657.
42. Boucher BA,Hannon TJ.Blood management: a primer for clinicians.Pharmacotherapy. 2007;27:1394-1411.
43. Nel TJ.Clinical guidelines, audits and hemovigilance in managing blood transfusion needs.Transfus Altern Transfus Med. 2008;10:61-69.
44. Spahn DR,Moch H,Hofmann A,Isbister JP.Patient blood management: the pragmatic solution for the problems with blood transfusions.Anesthesiology. 2008;109:951-953.
45. Tinmouth A,Macdougall L,Fergusson D, et al.Reducing the amount of blood transfused: a systematic review of behavioral interventions to change physicians' transfusion practices.Arch Intern Med. 2005;165:845-852.
46. Practice guidelines for blood component therapy: a report by the American Society of Anesthesiologists Task Force on Blood Component Therapy.Anesthesiology. 1996;84:732-747.
47. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies.Anesthesiology. 2006;105:198-208.
48. ProHealth. Experts find little evidence for transfusions improving health; much for potential harm. http://www.prohealth.com/library/showarticle.cfm?libid=14501. Accessed October 5, 2010.
49. Brevig J,McDonald J,Zelinka ES,Gallagher T,Jin R,Grunkemeier GL.Blood transfusion reduction in cardiac surgery: multidisciplinary approach at a community hospital.Ann Thorac Surg. 2009;87:532-539.
50. Goodnough LT,Shander A.Blood management.Arch Pathol Lab Med. 2007;131:695-701.
51. Rana R,Afessa B,Keegan MT, et al.Evidence-based red cell transfusion in the critically ill: quality improvement using computerized physician order entry.Crit Care Med. 2006;34:1892-1897.